1 Ocak 2017 Dergi makalesi Açık Erişim

Avci, H.; Epikmen, E. T.; Ipek, E.; Tunca, R.; Birincioglu, S. S.; Aksit, H.; Sekkin, S.; Akkoc, A. N.; Boyacioglu, M.

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Avci, H.</dc:creator>
  <dc:creator>Epikmen, E. T.</dc:creator>
  <dc:creator>Ipek, E.</dc:creator>
  <dc:creator>Tunca, R.</dc:creator>
  <dc:creator>Birincioglu, S. S.</dc:creator>
  <dc:creator>Aksit, H.</dc:creator>
  <dc:creator>Sekkin, S.</dc:creator>
  <dc:creator>Akkoc, A. N.</dc:creator>
  <dc:creator>Boyacioglu, M.</dc:creator>
  <dc:date>2017-01-01</dc:date>
  <dc:description>Introduction: Cyclophosphamide (CP) is a potent anticancer agent; its clinical use is limited due to its marked cardiotoxicity.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/45661</dc:identifier>
  <dc:identifier>oai:zenodo.org:45661</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY 69(5) 317-327</dc:source>
  <dc:title>Protective effects of silymarin and curcumin on cyclophosphamide-induced cardiotoxicity</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>